In September 2008, Grifols, SA, a global pharmaceutical company specializing in plasma-derived therapies, launched a patented online tracking system that will allow healthcare providers to trace the quality and safety of a specific drug from start to finish. Grifol’s PediGri® On Line system offers providers--physicians, nurses and pharmacists—a new way to follow a Grifols product from the source of the donated plasma to final distribution of the manufactured product. The information is accessed by entering the lot number, found on the factor product vial.

“Today, it is more important than ever that healthcare providers have confidence in the source of the medications they prescribe and administer,” said Bill Stopher, President of Grifols USA. “Grifols PediGri® provides an unparalleled level of information about the source and quality of the plasma used to produce Grifols’ therapies.”

Source: Grifols press release dated September 10, 2008